149 related articles for article (PubMed ID: 12947945)
1. UK watchdog investigates promotional children's book.
Pincock S
Lancet; 2003 Aug; 362(9384):625. PubMed ID: 12947945
[No Abstract] [Full Text] [Related]
2. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
3. Pharmaceutical manufacturers' compliance with drug advertisement regulations in Zimbabwe.
Sibanda N; Gavaza P; Maponga CC; Mugore L
Am J Health Syst Pharm; 2004 Dec; 61(24):2678-81. PubMed ID: 15646703
[No Abstract] [Full Text] [Related]
4. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
5. Selling drugs to the public--should the UK follow the example of the US?
Frey J
Br J Gen Pract; 2002 Feb; 52(475):170-1. PubMed ID: 11885831
[No Abstract] [Full Text] [Related]
6. Ethics in pharmaceutical advertising.
Lober CW
Dermatol Clin; 1993 Apr; 11(2):285-8. PubMed ID: 8477540
[TBL] [Abstract][Full Text] [Related]
7. Experimenting with direct-to-consumer advertising.
Lancet; 2000 Aug; 356(9230):607. PubMed ID: 10968426
[No Abstract] [Full Text] [Related]
8. Drug company accused of breaking advertising regulations.
Waechter F
BMJ; 2003 May; 326(7399):1106. PubMed ID: 12763970
[No Abstract] [Full Text] [Related]
9. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
Czerw A; Marek EM
Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
[TBL] [Abstract][Full Text] [Related]
10. No such thing as a free lunch.
Sandall J
Midwifery; 2008 Jun; 24(2):123-5. PubMed ID: 18378052
[No Abstract] [Full Text] [Related]
11. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
Kellerman R;
Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
[No Abstract] [Full Text] [Related]
12. UK regulator is to take lighter approach to drug advertisements.
Sukkar E
BMJ; 2013 Mar; 346():f1396. PubMed ID: 23457238
[No Abstract] [Full Text] [Related]
13. A review of FDA warning letters and notices of violation issued for patient-reported outcomes promotional claims between 2006 and 2012.
Symonds T; Hackford C; Abraham L
Value Health; 2014 Jun; 17(4):433-7. PubMed ID: 24969004
[TBL] [Abstract][Full Text] [Related]
14. Direct-to-consumer advertising of drugs.
Weinmeyer R
Virtual Mentor; 2013 Nov; 15(11):954-8. PubMed ID: 24257087
[No Abstract] [Full Text] [Related]
15. Selling drugs to doctors--it's marketing, not education.
Cooper R; Hoffman J
Br J Gen Pract; 2002 Feb; 52(475):168-9. PubMed ID: 11885830
[No Abstract] [Full Text] [Related]
16. Drug promotion: stealth, wealth, and safety.
Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382
[No Abstract] [Full Text] [Related]
17. Complaints about advertising of medicines are encouraged.
Simmonds H
BMJ; 2002 Apr; 324(7341):850-1. PubMed ID: 11934787
[No Abstract] [Full Text] [Related]
18. Medical ethics.
Bliznakov EG
Lancet; 2000 Oct; 356(9240):1522. PubMed ID: 11081556
[No Abstract] [Full Text] [Related]
19. Lundbeck broke advertising rules.
Dyer O
BMJ; 2003 May; 326(7397):1004. PubMed ID: 12742919
[No Abstract] [Full Text] [Related]
20. FDA considers tightening regulations for direct-to-consumer advertising.
Vastag B
J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
